Tristetraprolin impairs Myc-induced lymphoma and abolishes the malignant state

Cell

Volumn 150, Issue 3, 2012, Pages 563-574

  Rounbehler, Robert J ^a   Fallahi, Mohammad ^a   Yang, Chunying ^a   Steeves, Meredith A ^a   Li, Weimin ^a   Doherty, Joanne R ^a   Schaub, Franz X ^a   Sanduja, Sandhya ^b   Dixon, Dan A ^b   Blackshear, Perry J ^c   Cleveland, John L ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 7; MYC PROTEIN; TRISTETRAPROLIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CARCINOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOMA; LYMPHOPOIESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84864634079     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2012.06.033     Document Type: Article

References (57)

1. J.M. Adams, A.W. Harris, C.A. Pinkert, L.M. Corcoran, W.S. Alexander, S. Cory, R.D. Palmiter, and R.L. Brinster The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice Nature 318 1985 533 538
2. P.J. Blackshear Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover Biochem. Soc. Trans. 30 2002 945 952
3. S.E. Bodrug, B.J. Warner, M.L. Bath, G.J. Lindeman, A.W. Harris, and J.M. Adams Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene EMBO J. 13 1994 2124 2130
4. C.M. Brennan, and J.A. Steitz HuR and mRNA stability Cell. Mol. Life Sci. 58 2001 266 277
5. S.E. Brennan, Y. Kuwano, N. Alkharouf, P.J. Blackshear, M. Gorospe, and G.M. Wilson The mRNA-destabilizing protein tristetraprolin is suppressed in many cancers, altering tumorigenic phenotypes and patient prognosis Cancer Res. 69 2009 5168 5176
6. E. Carballo, and P.J. Blackshear Roles of tumor necrosis factor-alpha receptor subtypes in the pathogenesis of the tristetraprolin-deficiency syndrome Blood 98 2001 2389 2395
7. E. Carballo, W.S. Lai, and P.J. Blackshear Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin Science 281 1998 1001 1005
8. C.Y. Chen, and A.B. Shyu AU-rich elements: characterization and importance in mRNA degradation Trends Biochem. Sci. 20 1995 465 470
9. K. Chen, Y. Tu, Y. Zhang, H.C. Blair, L. Zhang, and C. Wu PINCH-1 regulates the ERK-Bim pathway and contributes to apoptosis resistance in cancer cells J. Biol. Chem. 283 2008 2508 2517
10. R. Dalla-Favera, M. Bregni, J. Erikson, D. Patterson, R.C. Gallo, and C.M. Croce Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells Proc. Natl. Acad. Sci. USA 79 1982 7824 7827
11. C.V. Dang c-Myc target genes involved in cell growth, apoptosis, and metabolism Mol. Cell. Biol. 19 1999 1 11
12. C.V. Dang, K.A. O'Donnell, K.I. Zeller, T. Nguyen, R.C. Osthus, and F. Li The c-Myc target gene network Semin. Cancer Biol. 16 2006 253 264
13. J.L. Dean, G. Sully, R. Wait, L. Rawlinson, A.R. Clark, and J. Saklatvala Identification of a novel AU-rich-element-binding protein which is related to AUF1 Biochem. J. 366 2002 709 719
14. D.A. Dixon, N.D. Tolley, P.H. King, L.B. Nabors, T.M. McIntyre, G.A. Zimmerman, and S.M. Prescott Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells J. Clin. Invest. 108 2001 1657 1665
15. C.M. Eischen, J.D. Weber, M.F. Roussel, C.J. Sherr, and J.L. Cleveland Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis Genes Dev. 13 1999 2658 2669
16. M. Fawal, F. Armstrong, S. Ollier, H. Dupont, C. Touriol, B. Monsarrat, G. Delsol, B. Payrastre, and D. Morello A "liaison dangereuse" between AUF1/hnRNPD and the oncogenic tyrosine kinase NPM-ALK Blood 108 2006 2780 2788
17. T.M. Franks, and J. Lykke-Andersen TTP and BRF proteins nucleate processing body formation to silence mRNAs with AU-rich elements Genes Dev. 21 2007 719 735
18. C. Gorrini, M. Squatrito, C. Luise, N. Syed, D. Perna, L. Wark, F. Martinato, D. Sardella, A. Verrecchia, and S. Bennett Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response Nature 448 2007 1063 1067
19. A. Gouble, S. Grazide, F. Meggetto, P. Mercier, G. Delsol, and D. Morello A new player in oncogenesis: AUF1/hnRNPD overexpression leads to tumorigenesis in transgenic mice Cancer Res. 62 2002 1489 1495
20. A.S. Halees, R. El-Badrawi, and K.S. Khabar ARED Organism: expansion of ARED reveals AU-rich element cluster variations between human and mouse Nucleic Acids Res. 36 Database issue 2008 D137 D140
21. J. Hemelaar, V.S. Lelyveld, B.M. Kessler, and H.L. Ploegh A single protease, Apg4B, is specific for the autophagy-related ubiquitin-like proteins GATE-16, MAP1-LC3, GABARAP, and Apg8L J. Biol. Chem. 278 2003 51841 51850
22. D.J. Hodson, M.L. Janas, A. Galloway, S.E. Bell, S. Andrews, C.M. Li, R. Pannell, C.W. Siebel, H.R. MacDonald, and K. De Keersmaecker Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia Nat. Immunol. 11 2010 717 724
23. M. Hummel, S. Bentink, H. Berger, W. Klapper, S. Wessendorf, T.F. Barth, H.W. Bernd, S.B. Cogliatti, J. Dierlamm, A.C. Feller Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling N. Engl. J. Med. 354 2006 2419 2430
24. M. Katz, I. Amit, A. Citri, T. Shay, S. Carvalho, S. Lavi, F. Milanezi, L. Lyass, N. Amariglio, and J. Jacob-Hirsch A reciprocal tensin-3-cten switch mediates EGF-driven mammary cell migration Nat. Cell Biol. 9 2007 961 969
25. U.B. Keller, J.B. Old, F.C. Dorsey, J.A. Nilsson, L. Nilsson, K.H. MacLean, L. Chung, C. Yang, C. Spruck, and K. Boyd Myc targets Cks1 to provoke the suppression of p27Kip1, proliferation and lymphomagenesis EMBO J. 26 2007 2562 2574
26. W.S. Lai, M.J. Thompson, G.A. Taylor, Y. Liu, and P.J. Blackshear Promoter analysis of Zfp-36, the mitogen-inducible gene encoding the zinc finger protein tristetraprolin J. Biol. Chem. 270 1995 25266 25272
27. H.H. Lee, M.T. Vo, H.J. Kim, U.H. Lee, C.W. Kim, H.K. Kim, M.S. Ko, W.H. Lee, S.J. Cha, and Y.J. Min Stability of the LATS2 tumor suppressor gene is regulated by tristetraprolin J. Biol. Chem. 285 2010 17329 17337
28. M. Marderosian, A. Sharma, A.P. Funk, R. Vartanian, J. Masri, O.D. Jo, and J.F. Gera Tristetraprolin regulates Cyclin D1 and c-Myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling Oncogene 25 2006 6277 6290
29. N. Meyer, and L.Z. Penn Reflecting on 25 years with MYC Nat. Rev. Cancer 8 2008 976 990
30. T. Miyamae, A.D. Marinov, D. Sowders, D.C. Wilson, J. Devlin, R. Boudreau, P. Robbins, and R. Hirsch Follistatin-like protein-1 is a novel proinflammatory molecule J. Immunol. 177 2006 4758 4762
31. M.A. Morrow, G. Lee, S. Gillis, G.D. Yancopoulos, and F.W. Alt Interleukin-7 induces N-myc and c-myc expression in normal precursor B lymphocytes Genes Dev. 6 1992 61 70
32. J.A. Nilsson, U.B. Keller, T.A. Baudino, C. Yang, S. Norton, J.A. Old, L.M. Nilsson, G. Neale, D.L. Kramer, C.W. Porter, and J.L. Cleveland Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation Cancer Cell 7 2005 433 444
33. M.W. Painter, S. Davis, R.R. Hardy, D. Mathis, C. Benoist Immunological Genome Project Consortium Transcriptomes of the B and T lineages compared by multiplatform microarray profiling J. Immunol. 186 2011 3047 3057
34. A. Pajic, D. Spitkovsky, B. Christoph, B. Kempkes, M. Schuhmacher, M.S. Staege, M. Brielmeier, J. Ellwart, F. Kohlhuber, and G.W. Bornkamm Cell cycle activation by c-myc in a burkitt lymphoma model cell line Int. J. Cancer 87 2000 787 793
35. G. Peters The D-type cyclins and their role in tumorigenesis J. Cell Sci. Suppl. 18 1994 89 96
36. K.R. Rosenbloom, T.R. Dreszer, M. Pheasant, G.P. Barber, L.R. Meyer, A. Pohl, B.J. Raney, T. Wang, A.S. Hinrichs, and A.S. Zweig ENCODE whole-genome data in the UCSC Genome Browser Nucleic Acids Res. 38 Database issue 2010 D620 D625
37. T. Sakai, L. Liu, X. Teng, R. Mukai-Sakai, H. Shimada, R. Kaji, T. Mitani, M. Matsumoto, K. Toida, and K. Ishimura Nucling recruits Apaf-1/pro-caspase-9 complex for the induction of stress-induced apoptosis J. Biol. Chem. 279 2004 41131 41140
38. S. Sanduja, V. Kaza, and D.A. Dixon The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase Aging (Albany NY) 1 2009 803 817
39. T.K. Sengupta, S. Bandyopadhyay, D.J. Fernandes, and E.K. Spicer Identification of nucleolin as an AU-rich element binding protein involved in bcl-2 mRNA stabilization J. Biol. Chem. 279 2004 10855 10863
40. J. Seoane, C. Pouponnot, P. Staller, M. Schader, M. Eilers, and J. Massagué TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b Nat. Cell Biol. 3 2001 400 408
41. P. Staller, K. Peukert, A. Kiermaier, J. Seoane, J. Lukas, H. Karsunky, T. Möröy, J. Bartek, J. Massagué, F. Hänel, and M. Eilers Repression of p15INK4b expression by Myc through association with Miz-1 Nat. Cell Biol. 3 2001 392 399
42. G. Stoecklin, B. Gross, X.F. Ming, and C. Moroni A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNA Oncogene 22 2003 3554 3561
43. S. Tabrizifard, A. Olaru, J. Plotkin, M. Fallahi-Sichani, F. Livak, and H.T. Petrie Analysis of transcription factor expression during discrete stages of postnatal thymocyte differentiation J. Immunol. 173 2004 1094 1102
44. R. Taub, I. Kirsch, C. Morton, G. Lenoir, D. Swan, S. Tronick, S. Aaronson, and P. Leder Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells Proc. Natl. Acad. Sci. USA 79 1982 7837 7841
45. G.A. Taylor, E. Carballo, D.M. Lee, W.S. Lai, M.J. Thompson, D.D. Patel, D.I. Schenkman, G.S. Gilkeson, H.E. Broxmeyer, B.F. Haynes, and P.J. Blackshear A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency Immunity 4 1996 445 454
46. E.S. Tobias, A.F. Hurlstone, E. MacKenzie, R. McFarlane, and D.M. Black The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein Oncogene 20 2001 2844 2853
47. Q. Wang, S. Diskin, E. Rappaport, E. Attiyeh, Y. Mosse, D. Shue, E. Seiser, J. Jagannathan, S. Shusterman, and M. Bansal Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number Cancer Res. 66 2006 6050 6062
48. K.I. Zeller, A.G. Jegga, B.J. Aronow, K.A. O'Donnell, and C.V. Dang An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets Genome Biol. 4 2003 R69
49. K.I. Zeller, X. Zhao, C.W. Lee, K.P. Chiu, F. Yao, J.T. Yustein, H.S. Ooi, Y.L. Orlov, A. Shahab, and H.C. Yong Global mapping of c-Myc binding sites and target gene networks in human B cells Proc. Natl. Acad. Sci. USA 103 2006 17834 17839
50. Lai, W.S., Stumpo, D.J., and Blackshear, P.J. (1990). Rapid insulin-stimulated accumulation of an mRNA encoding a proline-rich protein. J. Biol. Chem. 265, 16556-16563.
51. LaTulippe, E., Satagopan, J., Smith, A., Scher, H., Scardino, P., Reuter, V., and Gerald, W.L. (2002). Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res. 62, 4499-4506.
52. Matsuyama, T., Ishikawa, T., Mogushi, K., Yoshida, T., Iida, S., Uetake, H., Mizushima, H., Tanaka, H., and Sugihara, K. (2010). MUC12 mRNA expression is an independent marker of prognosis in stage II and stage III colorectal cancer. Int. J. Cancer 127, 2292-2299.
53. Shi, J., Fallahi, M., Luo, J.L., and Petrie, H.T. (2011). Nonoverlapping functions for Notch1 and Notch3 during murine steady-state thymic lymphopoiesis. Blood 118, 2511-2519.
54. Skrzypczak, M., Goryca, K., Rubel, T., Paziewska, A., Mikula, M., Jarosz, D., Pachlewski, J., Oledzki, J., and Ostrowski, J. (2010). Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability. PLoS ONE 5, e13091.
55. Varnum, B.C., Ma, Q.F., Chi, T.H., Fletcher, B., and Herschman, H.R. (1991). The TIS11 primary response gene is a member of a gene family that encodes proteins with a highly conserved sequence containing an unusual Cys-His repeat. Mol. Cell. Biol. 11, 1754-1758.
56. Wang, Y., Klijn, J.G., Zhang, Y., Sieuwerts, A.M., Look, M.P., Yang, F., Talantov, D., Timmermans, M., Meijer-van Gelder, M.E., Yu, J., et al. (2005). Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365, 671-679.
57. Young, L.E., Sanduja, S., Bemis-Standoli, K., Pena, E.A., Price, R.L., and Dixon, D.A. (2009). The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis. Gastroenterology 136, 1669-1679.